Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CRHBP | P24387 | 2/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.44 |
| ▸ | PRKACA | P17612 | 1/20 | 0.44 |
| ▸ | CASP6 | P55212 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14951396 | 0.84 | HPRT1 (0.60) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL1767571 | 0.83 | ALDH1A1 (0.63) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL29236231 | 0.80 | ALDH1A1 (0.59) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL29914892 | 0.80 | HPRT1 (0.59) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL31548579 | 0.80 | HPRT1 (0.59) | HPRT1TDP1CASP6POLBLMNA | |
| SCHEMBL6934366 | 0.79 | ALDH1A1 (0.58) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL28291132 | 0.78 | ALDH1A1 (0.57) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL6396044 | 0.78 | ALDH1A1 (0.57) | HPRT1ALDH1A1TDP1CRHBPCRHR2 | |
| SCHEMBL17459514 | 0.77 | HPRT1 (0.63) | HPRT1ALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL10435064 | 0.77 | HPRT1 (0.53) | HPRT1ALDH1A1TDP1CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111128567-B | Preparation method of organic prelithiation material | 中国电子科技集团公司第十八研究所 | 2022-03-22 | — | — | CN | disclosed |
| CN-111128567-A | Preparation method of organic prelithiation material | 中国电子科技集团公司第十八研究所 | 2020-05-08 | — | — | CN | disclosed |
| US-20170204091-A1 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES | LIGHTWAVE LOGIC INC (US) | 2017-07-20 | — | — | US | disclosed |
| US-9575423-B2 | Electrophotographic photosensitive member | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9575423-B2 | Electrophotographic photosensitive member | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20150253682-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150253682-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20140121376-A1 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES | LIGHTWAVE LOGIC, INC. (US) | 2014-05-01 | — | — | US | disclosed |
| US-7894695-B2 | Tricyclic spacer systems for nonlinear optical devices | LIGHTWAVE LOGIC, INC. | 2011-02-22 | — | — | US | disclosed |
| US-20080009620-A1 | Tricyclic Spacer Systems For Nonlinear Optical Devices | THIRD-ORDER NANOTECHNOLOGIES, INC. (US) | 2008-01-10 | — | — | US | disclosed |
| US-5151271-A | Composites for drug delivery for skin absorption | NITTI ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1992-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009620-A1 | Tricyclic Spacer Systems For Nonlinear Optical Devices | AQP4, CCND3, CDK14 | HPRT1 3334/4885ALDH1A1 3822/4885TDP1 2599/4885 |
| US-20140121376-A1 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES | AQP4, CCND3, CDK14 | HPRT1 3334/4885ALDH1A1 3822/4885TDP1 2599/4885 |
| US-20170204091-A1 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES | CCND3, CCNY, CCND2 | HPRT1 2829/4885ALDH1A1 3982/4885TDP1 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.